News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
415,853 Results
Type
Article (30534)
Company Profile (91)
Press Release (385225)
Multimedia
Podcasts (114)
Webinars (14)
Section
Business (130269)
Career Advice (1165)
Deals (20144)
Drug Delivery (132)
Drug Development (57693)
Employer Resources (96)
FDA (10062)
Job Trends (8995)
News (207610)
Policy (23260)
Tag
2025 Best Places to Work (8)
2026 Best Places to Work (16)
2027 BioCapital Standard (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Digital (1)
2027 Biotech Beach Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (1)
40 Under 40 (3)
Academia (1541)
Accelerated approval (48)
ADA (17)
Adcomms (26)
Allergies (181)
Alliances (30558)
ALS (165)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (403)
Approvals (10610)
Artificial intelligence (526)
ASCO (180)
Autoimmune disease (233)
Automation (37)
Bankruptcy (198)
Belgium (15)
Best Places to Work (6819)
BIO (37)
Biologics (72)
BIOSECURE Act (14)
Biosimilars (237)
BioSpace Insights (92)
Biotechnology (48)
Bispecific (27)
Bladder cancer (129)
Brain cancer (72)
Breast cancer (462)
Cancer (3988)
Cardiovascular disease (385)
Career advice (1018)
Career pathing (33)
CAR-T (199)
CDC (53)
CDMO (148)
Celiac Disease (3)
Cell-line development (1)
Cell therapy (556)
Cervical cancer (35)
Clinical research (50678)
Collaboration (1629)
Commercialization (43)
Company closure (4)
Compensation (682)
Complete response letters (73)
COVID-19 (2484)
CRISPR (92)
CRO (3)
C-suite (1021)
Cystic fibrosis (95)
Data (6410)
Decentralized trials (3)
Denatured (23)
Depression (133)
Dermatology (127)
Diabetes (439)
Diagnostics (3043)
Digital health (34)
Diversity (7)
Diversity, equity & inclusion (33)
Drug discovery (304)
Drug pricing (171)
Drug shortages (29)
Duchenne muscular dystrophy (270)
Earnings (46792)
Editorial (55)
Employer branding (10)
Employer resources (95)
ESMO (215)
Events (59788)
Executive appointments (833)
Eye disease (21)
FDA (13067)
Fibrodysplasia Ossificans Progressiva (10)
Fragile X (4)
Friedreich's ataxia (19)
Frontotemporal dementia (29)
Funding (1169)
Gene editing (167)
Generative AI (57)
Gene therapy (582)
GLP-1 (816)
Government (3321)
Grass and pollen (7)
Guidances (271)
Healthcare (8662)
Hematology (129)
HIV (74)
Huntington's disease (57)
Idiopathic pulmonary fibrosis (4)
IgA nephropathy (93)
Immunology and inflammation (197)
Immuno-oncology (82)
Indications (207)
Infectious disease (2834)
Inflammatory bowel disease (146)
Inflation Reduction Act (10)
Influenza (130)
Intellectual property (216)
Interviews (203)
IPO (8308)
IRA (45)
Job creations (2424)
Job search strategy (853)
JPM (43)
Kidney cancer (19)
Kidney disease (106)
Labor market (71)
Layoffs (348)
Leadership (35)
Legal (6689)
Licensing (95)
Liver cancer (52)
Longevity (48)
Lung cancer (568)
Lung diease (9)
Lymphoma (314)
Machine learning (32)
Management (34)
Manufacturing (944)
Marketing (29)
MASH (130)
Medical affairs (4)
Medical device (3848)
Medtech (3931)
Mergers & acquisitions (12727)
Metabolic disorders (1157)
Middle East (2)
mRNA (225)
Multiple sclerosis (179)
Multispecific (1)
NASH (15)
Netherlands (13)
Neurodegenerative disease (361)
Neuropsychiatric disorders (107)
Neuroscience (2850)
Neurotech (2)
NextGen: Class of 2026 (3064)
Non-profit (2235)
Now hiring (32)
Obesity (546)
Opinion (255)
Ovarian cancer (159)
Pain (205)
Pancreatic cancer (205)
Parkinson's disease (288)
Partnered (20)
Patents (481)
Patient advocacy (6)
Patient recruitment (470)
Patient selection (56)
Peanut (61)
People (37060)
Peptides (29)
Pharmaceutical (38)
Pharmacy benefit managers (24)
Phase 1 (14552)
Phase 2 (21855)
Phase 3 (18151)
Pipeline (8689)
Policy (265)
Postmarket research (1956)
Preclinical (6274)
Press Release (37)
Prostate cancer (205)
Psychedelics (70)
Radioligand (1)
Radiopharmaceuticals (273)
Rare diseases (1024)
Real estate (3240)
Recruiting (39)
Regenerative medicine (13)
Regulatory (17899)
Reports (35)
Research institute (1469)
Resumes & cover letters (174)
Rett syndrome (47)
RNA editing (16)
RSV (99)
Saudi Arabia (1)
Schizophrenia (156)
Series A (199)
Series B (126)
Service/supplier (2)
Sickle cell disease (94)
Special edition (20)
Spinal muscular atrophy (158)
Sponsored (28)
Startups (2187)
State (2)
Stem cells (6)
Stomach cancer (17)
Substance use disorders (13)
Supply chain (102)
Switzerland (20)
Tariffs (87)
The Weekly (89)
Vaccines (1200)
Venture capital (88)
Weight loss (359)
Wet AMD (7)
Women's health (100)
Worklife (12)
Date
Today (131)
Last 7 days (528)
Last 30 days (2042)
Last 365 days (17107)
2026 (15466)
2025 (17130)
2024 (19934)
2023 (22651)
2022 (30892)
2021 (32799)
2020 (30579)
2019 (24535)
2018 (18869)
2017 (19435)
2016 (18904)
2015 (21750)
2014 (17128)
2013 (14166)
2012 (15020)
2011 (15771)
2010 (14476)
Location
Africa (548)
Alabama (38)
Alaska (2)
Arizona (179)
Arkansas (6)
Asia (28781)
Australia (4522)
California (8099)
Canada (2799)
China (1311)
Colorado (370)
Connecticut (319)
Delaware (299)
Europe (64396)
Florida (1491)
Georgia (227)
Hawaii (4)
Idaho (20)
Illinois (787)
India (122)
Indiana (527)
Iowa (7)
Japan (562)
Kansas (106)
Kentucky (36)
Louisiana (29)
Maine (36)
Maryland (1034)
Massachusetts (6183)
Michigan (123)
Minnesota (339)
Mississippi (3)
Missouri (82)
Montana (13)
Nebraska (9)
Nevada (64)
New Hampshire (26)
New Jersey (2887)
New Mexico (15)
New York (2505)
North Carolina (1172)
North Dakota (4)
Northern California (4078)
Ohio (186)
Oklahoma (9)
Oregon (21)
Pennsylvania (1788)
Puerto Rico (25)
Rhode Island (32)
South America (750)
South Carolina (27)
South Dakota (1)
Southern California (3378)
Tennessee (124)
Texas (1163)
United States (30378)
Utah (161)
Vermont (1)
Virginia (277)
Washington D.C. (55)
Washington State (638)
West Virginia (1)
Wisconsin (104)
Wyoming (4)
415,853 Results for "cns pharmaceuticals ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
November 16, 2026
·
5 min read
Press Releases
CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth
September 1, 2026
·
3 min read
Press Releases
CNS Pharmaceuticals Participates in the Virtual Investor “Why Now” On-Demand Conference
August 27, 2026
·
3 min read
Press Releases
Oxford Brain Diagnostics Wins 2026 CNS Summit Innovation Showcase
November 5, 2026
·
3 min read
Press Releases
Supernus and Indivior Complete Merger Creating a Diversified CNS Biopharmaceutical Leader
November 2, 2026
·
9 min read
Press Releases
Supernus Pharmaceuticals and Indivior Pharmaceuticals to Merge, Creating a Diversified CNS Biopharmaceutical Leader with Significant Scale
August 3, 2026
·
15 min read
M&A
Supernus and Indivior merge to create CNS mega-company with 11 approved drugs
Supernus Pharmaceuticals and Indivior Pharmaceuticals are outlining a combined expected $2.2 billion in annual revenue, plus $125 million in cost savings that will include “natural redundancies.”
August 3, 2026
·
3 min read
·
Gabrielle Masson
Press Releases
CNS Pharmaceuticals Reports Second Quarter 2026 Results, Highlighting Strengthened Balance Sheet and Accelerated Execution of Strategic Transformation
August 12, 2026
·
6 min read
Press Releases
MustGrow Receives First Milestone Payment from Bayer AG
• Bayer AG has paid MustGrow the first development milestone payment. • The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow’s mustard-based biocontrol technologies in Europe, Middle East and Africa.
August 21, 2026
·
6 min read
Press Releases
CNS Pharmaceuticals Announces Oversubscribed $22.5 Million Private Placement Financing
May 4, 2026
·
6 min read
1 of 41,586
Next